$350 | Single User
$700 | Site License
$1050 | Enterprise License

Pharmaceuticals in China [Report Updated: 06-06-2018]

Published by Marketline: 06 Jun 2018 | 218170 | In Stock

Introduction

Pharmaceuticals in China

Summary

Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the China pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Chinese pharmaceuticals market had total revenues of 8.3bn in 2017, representing a compound annual growth rate (CAGR) of 9.9% between 2013 and 2017.

- An aging population and rapid growth of chronic diseases has fuelled the demand for pharmaceutical products.

- Growth in the Chines market is helped by rapid increases in spending on healthcare, although the continued popularity of traditional Chinese medicine limits the benefits felt by the pharmaceutical companies.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in China

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China

- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the China pharmaceuticals market by value in 2017?

- What will be the size of the China pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the China pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in China's pharmaceuticals market?

Table of Contents
for Pharmaceuticals in China [Report Updated: 06-06-2018]

  • Table of Contents

    Executive Summary 2

    Market value 2

    Market value forecast 2

    Geography segmentation 2

    Market share 2

    Market rivalry 2

    Market Overview 7

    Market definition 7

    Market analysis 7

    Market Data 9

    Market value 9

    Market Segmentation 10

    Geography segmentation 10

    Market share 11

    Market Outlook 12

    Market value forecast 12

    Five Forces Analysis 13

    Summary 13

    Buyer power 14

    Supplier power 16

    New entrants 17

    Threat of substitutes 19

    Degree of rivalry 20

    Leading Companies 22

    Guangzhou Pharmaceutical Holdings Limited 22

    Shanghai Pharmaceutical Co Ltd 23

    Yangtze River Pharmaceutical Group 26

    Yunnan Baiyao Group Co Ltd 27

    Macroeconomic Indicators 30

    Country data 30

    Methodology 32

    Industry associations 33

    Related MarketLine research 33

    Appendix 34

    About MarketLine 34

List Of Tables
in Pharmaceuticals in China [Report Updated: 06-06-2018]

List of Tables

Table 1: China pharmaceuticals market value: $ billion, 2013-17

Table 2: China pharmaceuticals market geography segmentation: $ billion, 2017

Table 3: China pharmaceuticals market share: % share, by value, 2017

Table 4: China pharmaceuticals market value forecast: $ billion, 2017-22

Table 5: Guangzhou Pharmaceutical Holdings Limited: key facts

Table 6: Shanghai Pharmaceutical Co Ltd: key facts

Table 7: Shanghai Pharmaceutical Co Ltd: key financials ($)

Table 8: Shanghai Pharmaceutical Co Ltd: key financials (CNY)

Table 9: Shanghai Pharmaceutical Co Ltd: key financial ratios

Table 10: Yangtze River Pharmaceutical Group: key facts

Table 11: Yunnan Baiyao Group Co Ltd: key facts

Table 12: Yunnan Baiyao Group Co Ltd: key financials ($)

Table 13: Yunnan Baiyao Group Co Ltd: key financials (CNY)

Table 14: Yunnan Baiyao Group Co Ltd: key financial ratios

Table 15: China size of population (million), 2013-17

Table 16: China gdp (constant 2005 prices, $ billion), 2013-17

Table 17: China gdp (current prices, $ billion), 2013-17

Table 18: China inflation, 2013-17

Table 19: China consumer price index (absolute), 2013-17

Table 20: China exchange rate, 2013-17

List Of Figures, Charts and Diagrams
in Pharmaceuticals in China [Report Updated: 06-06-2018]

List of Figures

Figure 1: China pharmaceuticals market value: $ billion, 2013-17

Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: China pharmaceuticals market share: % share, by value, 2017

Figure 4: China pharmaceuticals market value forecast: $ billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in China, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in China, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in China, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in China, 2017

Figure 11: Shanghai Pharmaceutical Co Ltd: revenues & profitability

Figure 12: Shanghai Pharmaceutical Co Ltd: assets & liabilities

Figure 13: Yunnan Baiyao Group Co Ltd: revenues & profitability

Figure 14: Yunnan Baiyao Group Co Ltd: assets & liabilities

Additional Details

Publisher

Marketline

Publisher Information

Reference

218170 |

Number of Pages

35

Report Format

PDF

Marketline Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Alexion Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Alnylam Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
AMAG Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Amylin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
BioCryst Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Biomarin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Enzon Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Essilor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Isis Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
NPS Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info

This report is published by Marketline

Download Free Report Summary PDF

Pharmaceuticals in China [Report Updated: 06-06-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data